On last night's "MAD MONEY" on CNBC, Jim Cramer wanted to show defensive stocks in the medical industrial field. He has seen enough earnings from big companies and he is fed up with the Fed sitting around while the U.S. economy is slowing to a halt. He wants an "Ultimate Defensive Portfolio" of three stocks that are defensive but whose businesses are still growing. He even wanted to take out the companies that are only growing because of foreign business.

1) Bard (C.R.) (NYSE: BCR) is one stock he's been behind since 2005, and he is still behind it. Besides thinking it can still be bought, there is more to like on it, especially its catheter business, but its biopsy technology and the angioplasty operations as well.

2) Becton, Dickinson (NYSE: BDX) is a safe traditional medical device and diagnostics company. BDX has been up 31% since Cramer first recommended it, and he thinks it will go higher. More on BDX here.

3) Baxter International Inc. (NYSE: BAX) was Cramer's #3 spot as the best of breed, but he only wants to buy it now if it sells off. You can read what else he noted on it.

Back in February I came up with a list of 20 Defensive Stocks for a Crummy Market. After those 20 stocks, I even came up with a list of 15 Second Line Defensive Stocks. Many of my names were different than Cramer's names at the time. Some of my picks were medical and some were not, and most were chosen at a time that fear and panic were starting to come front and center. These picks that Cramer came up with are all different in that they may grow, and not only because of the weak dollar.

Jon Ogg is a partner at 24.7 Wall St.; he does not own securities in the companies he covers.